PAVmed Inc (PAVM)
1.46
+0.02
(+1.39%)
USD |
NASDAQ |
May 31, 16:00
1.48
+0.02
(+1.37%)
After-Hours: 20:00
PAVmed Research and Development Expense (TTM): 12.17M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.17M |
| December 31, 2023 | 14.28M |
| September 30, 2023 | 17.35M |
| June 30, 2023 | 20.40M |
| March 31, 2023 | 23.67M |
| December 31, 2022 | 25.55M |
| September 30, 2022 | 25.84M |
| June 30, 2022 | 24.95M |
| March 31, 2022 | 22.46M |
| December 31, 2021 | 19.85M |
| September 30, 2021 | 16.52M |
| June 30, 2021 | 13.83M |
| March 31, 2021 | 11.71M |
| December 31, 2020 | 11.02M |
| September 30, 2020 | 9.634M |
| June 30, 2020 | 8.535M |
| March 31, 2020 | 7.807M |
| Date | Value |
|---|---|
| December 31, 2019 | 6.63M |
| September 30, 2019 | 5.744M |
| June 30, 2019 | 5.397M |
| March 31, 2019 | 5.141M |
| December 31, 2018 | 4.253M |
| September 30, 2018 | 3.443M |
| June 30, 2018 | 2.975M |
| March 31, 2018 | 2.528M |
| December 31, 2017 | 2.622M |
| September 30, 2017 | 2.670M |
| June 30, 2017 | 2.544M |
| March 31, 2017 | 2.197M |
| December 31, 2016 | 1.720M |
| September 30, 2016 | 1.254M |
| June 30, 2016 | 0.94M |
| March 31, 2016 | 0.6525M |
| December 31, 2015 | 0.4893M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.397M
Minimum
Jun 2019
25.84M
Maximum
Sep 2022
15.17M
Average
14.05M
Median
Research and Development Expense (TTM) Benchmarks
| Cutera Inc | 19.94M |
| Dynatronics Corp | -- |
| Stereotaxis Inc | 9.77M |
| Electromed Inc | 0.778M |
| Myomo Inc | 3.116M |